Biotechnology Law at Papua New Guinea
Papua New Guinea (PNG) has established a foundational framework for biotechnology regulation, focusing on biosafety and the safe use of genetically modified organisms (GMOs). While the country has made significant strides in policy development, the implementation of these frameworks remains a work in progress.
🇵🇬 Legal and Institutional Framework
1. Cartagena Protocol on Biosafety (2005)
PNG ratified the Cartagena Protocol on Biosafety in 2005, committing to the safe handling, transport, and use of living modified organisms (LMOs) resulting from modern biotechnology. This international agreement aims to protect biological diversity from potential risks posed by GMOs.
2. Draft Biosafety and Biotechnology Policy and Bill (2005)
Developed by the National Biosafety and Biotechnology Committee (NBBC), the draft policy and bill outline the regulatory framework for GMOs in PNG. The policy addresses key issues such as environmental protection, trade, research and development, and stakeholder involvement. The bill aims to regulate dealings with GMOs to ensure safety and sustainability.
3. National Focal Point – Conservation and Environment Protection Authority (CEPA)
The CEPA serves as the national focal point for biosafety matters in PNG. However, the NBBC, responsible for coordinating biosafety activities, remains dormant, leading to delays in policy implementation and GMO approvals.
🔬 Biotechnology Research and Applications
Biotechnology research in PNG is primarily conducted by institutions such as the Papua New Guinea University of Technology (UNITECH) and the National Agricultural Research Institute (NARI). Current research activities are limited to in vitro techniques and tissue culture, with a focus on crops like oil palm. These institutions emphasize the need for adequate infrastructure, biosafety regulatory frameworks, and capacity building to advance biotechnology applications.
⚠️ Implementation Challenges
Despite the development of policies and frameworks, PNG faces several challenges in implementing biotechnology regulations:
Inactive Biosafety Committee: The NBBC's inactivity hampers the approval process for GMOs and the development of necessary regulations.
Limited Institutional Capacity: There is a need to strengthen human and institutional capacities for risk assessment and management of GMOs.
Public Awareness: Increasing public awareness and participation in biosafety matters is essential for informed decision-making.
🌐 International Commitments
In addition to the Cartagena Protocol, PNG is a party to the Convention on Biological Diversity, which provides a broader framework for the conservation and sustainable use of biodiversity. These international commitments underscore PNG's dedication to biosafety and the responsible use of biotechnology.
RELATED Blog
0 comments